CoChat

Skin-on-a-chip model simulating inflammation, edema and drug-based treatment

Open access
Wufuer, Maierdanjiang, Lee, GeonHui, Hur, Woojune, Jeon, Byoungjun, Kim, Byung Jun, Choi, Tae Hyun, Lee, SangHoon · 2016 · Scientific Reports

The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.

Abstract

Recent advances in microfluidic cell cultures enable the construction of in vitro human skin models that can be used for drug toxicity testing, disease study. However, current in vitro skin model have limitations to emulate real human skin due to the simplicity of model. In this paper, we describe the development of ‘skin-on-a-chip’ to mimic the structures and functional responses of the human skin. The proposed model consists of 3 layers, on which epidermal, dermal and endothelial components originated from human, were cultured. The microfluidic device was designed for co-culture of human skin cells and each layer was separated by using porous membranes to allow interlayer communication. Skin inflammation and edema were induced by applying tumor necrosis factor alpha on dermal layer to demonstrate the functionality of the system. The expression levels of proinflammatory cytokines were analyzed to illustrate the feasibility. In addition, we evaluated the efficacy of therapeutic drug testing model using our skin chip. The function of skin barrier was evaluated by staining tight junctions and measuring a permeability of endothelium. Our results suggest that the skin-on-a-chip model can potentially be used for constructing in vitro skin disease models or for testing the toxicity of cosmetics or drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep37471

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Description of the microfluidic device. (a) Image of a skin-on-a-chip device filled with fluid three different colors. (b) 3D scheme of the skin-on-a-chip system comprising three PDMS layers and two PET porous membranes (footprint: 48 mm × 26 mm; height: 7 mm). (c) SEM image of PET porous membranes (pore size: 0.4 μm) obtained from Transwell. (d) Cross-sectional image of A–A’. (e) Schematic of the skin-on-a-chip system, including three separate channels with four vertically stacked cell layers. (f) Representative histological skin section stained with hematoxylin and eosin to indicate the cellular organization of skin.
Figure 1 Description of the microfluidic device. (a) Image of a skin-on-a-chip device filled with fluid three different colors. (b) 3D scheme of the skin-on-a-chip system comprising three PDMS layers and two PET porous membranes (footprint: 48 mm × 26 mm; height: 7 mm). (c) SEM image of PET porous membranes (pore size: 0.4 μm) obtained from Transwell. (d) Cross-sectional image of A–A’. (e) Schematic of the skin-on-a-chip system, including three separate channels with four vertically stacked cell layers. (f) Representative histological skin section stained with hematoxylin and eosin to indicate the cellular organization of skin.CC BY · PubMed Central
Figure 2 Optical images of cells in a skin-on-a-chip device. Images of confluent HaCaT (a), Fb (b) and HUVEC (c) monolayers at day 3 in the microfluidic devices. (d) Fbs and HUVECs were cultured on the top and bottom, respectively, of the lower porous membrane in the microfluidic device. The red-dotted circle in each figure depicts the location of the area shown in the microscopic image. Scale bars: 150 μm. HaCaT, human immortalized keratinocyte; Fb, fibroblast; HUVEC, human umbilical vein endothelial cell.
Figure 2 Optical images of cells in a skin-on-a-chip device. Images of confluent HaCaT (a), Fb (b) and HUVEC (c) monolayers at day 3 in the microfluidic devices. (d) Fbs and HUVECs were cultured on the top and bottom, respectively, of the lower porous membrane in the microfluidic device. The red-dotted circle in each figure depicts the location of the area shown in the microscopic image. Scale bars: 150 μm. HaCaT, human immortalized keratinocyte; Fb, fibroblast; HUVEC, human umbilical vein endothelial cell.CC BY · PubMed Central
Figure 3 Images of (a) HaCaTs, (b) Fbs and (c) HUVECs immunostained with Cell TrackerTM. (d) Schematic of the side view of a skin-on-a-chip device. (e) Four layers with three cell types were stacked on two porous membranes. Z-stacked fluorescence image showing that all cells adhered to the PET membranes. (f) 3D fluorescence image of the cross section (A-A’) of a microfluidic device. Scale bars: 300 μm.
Figure 3 Images of (a) HaCaTs, (b) Fbs and (c) HUVECs immunostained with Cell TrackerTM. (d) Schematic of the side view of a skin-on-a-chip device. (e) Four layers with three cell types were stacked on two porous membranes. Z-stacked fluorescence image showing that all cells adhered to the PET membranes. (f) 3D fluorescence image of the cross section (A-A’) of a microfluidic device. Scale bars: 300 μm.CC BY · PubMed Central
Figure 4 Inducing inflammation in the skin-on-a-chip system. (a) Representative figures showing the mRNA expression levels and intensity for the pro-inflammatory mediators (IL-1β, IL-6 and IL-8) in HUVECs stimulated by TNF-α. (b) Levels of IL-1β, IL-6 and IL-8 secreted from HUVECs following stimulation with different concentrations of TNF-α for 24 hours, as measured by a multiplex assay (n = 3, *p < 0.05).
Figure 4 Inducing inflammation in the skin-on-a-chip system. (a) Representative figures showing the mRNA expression levels and intensity for the pro-inflammatory mediators (IL-1β, IL-6 and IL-8) in HUVECs stimulated by TNF-α. (b) Levels of IL-1β, IL-6 and IL-8 secreted from HUVECs following stimulation with different concentrations of TNF-α for 24 hours, as measured by a multiplex assay (n = 3, *p < 0.05).CC BY · PubMed Central
Figure 5 Pharmaceutical treatment of the skin-on-a-chip system. (a) The levels and intensity of secreted pro-inflammatory cytokine mRNA in HUVECs were analyzed by RT-PCR. (b) The released levels of IL-1β1b, IL-6, and IL-8 in the HUVEC culture medium were measured by a multiplex assay (n = 3, *p < 0.05).
Figure 5 Pharmaceutical treatment of the skin-on-a-chip system. (a) The levels and intensity of secreted pro-inflammatory cytokine mRNA in HUVECs were analyzed by RT-PCR. (b) The released levels of IL-1β1b, IL-6, and IL-8 in the HUVEC culture medium were measured by a multiplex assay (n = 3, *p < 0.05).CC BY · PubMed Central
Figure 6 Immunocytochemical tight junction staining in HUVECs. Distribution of the tight junction protein ZO-1 in a non-treated chip (control), a TNF-α-treated (50 ng/ml) chip and a Dex-treated (1,000 nM) chip, as observed with immunofluorescence microscopy. (a–c) DAPI staining showing the distribution of HUVEC nuclei. (d–f) Images of ZO-1 staining and (g–i) merged images depicting the HUVEC tight junctions. Gaps were observed in the TNF-α-treat chip (e,h), and Dex prevented this TNF-α-induced disruption of the tight junctions (f,i). Scale bars: 100 μm. Dex, Dexamethasone.
Figure 6 Immunocytochemical tight junction staining in HUVECs. Distribution of the tight junction protein ZO-1 in a non-treated chip (control), a TNF-α-treated (50 ng/ml) chip and a Dex-treated (1,000 nM) chip, as observed with immunofluorescence microscopy. (a–c) DAPI staining showing the distribution of HUVEC nuclei. (d–f) Images of ZO-1 staining and (g–i) merged images depicting the HUVEC tight junctions. Gaps were observed in the TNF-α-treat chip (e,h), and Dex prevented this TNF-α-induced disruption of the tight junctions (f,i). Scale bars: 100 μm. Dex, Dexamethasone.CC BY · PubMed Central
Figure 7 Permeability and therapeutic analysis of the on-chip skin edema model. (a) Schematic of the human skin edema model. Inflammation induced by TNF-α damages tight junctions, resulting in vascular leakage. (b) Schematic of the skin edema model in a microfluidic device with TNF-α exposure after a Dex pretreatment (c) TNF-α-treated chips exhibited increased paracellular permeability to FITC-dextran (4 kDa) compared with non-treated chips. The permeability of Dex-treated chips was significantly lower than that of chips treated only with TNF-α.
Figure 7 Permeability and therapeutic analysis of the on-chip skin edema model. (a) Schematic of the human skin edema model. Inflammation induced by TNF-α damages tight junctions, resulting in vascular leakage. (b) Schematic of the skin edema model in a microfluidic device with TNF-α exposure after a Dex pretreatment (c) TNF-α-treated chips exhibited increased paracellular permeability to FITC-dextran (4 kDa) compared with non-treated chips. The permeability of Dex-treated chips was significantly lower than that of chips treated only with TNF-α.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Research works printed but not linked: 1

  1. Ramadan, Q. & Ting, F. C. W. In vitro micro-physiological immune-competent model of the human skin. Lab Chip 16, 1899–1908 (2016). · DOI · Paper page

Cited by

Metadata

Authors
Wufuer, M., Lee, G., Hur, W., Jeon, B., Kim, B. J., Choi, T. H., & Lee, S.
Affiliations
  • Seoul National University (KR)
  • Korea University (KR)
Corresponding author
Choi, Tae Hyun
Venue
Scientific Reports
Published
2016-11-21
Volume
6
Issue
1
Pages
37471-37471
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2550854745
Cited by
356
References
54
Citations by year
2026: 39 · 2025: 32 · 2024: 40 · 2023: 36 · 2022: 50 · 2021: 52 · 2020: 35 · 2019: 24 · 2018: 36 · 2017: 12
FWCI
11.55
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Ministry of Food and Drug Safety (16182MFDS526)
  • Korea Institute of Science and Technology
  • Korea Research Institute of Bioscience and Biotechnology (KGM4891511)
  • Ministry of Public Safety and Security (MPSS-CG-2016-02)
  • KU-KIST Graduate School of Converging Science and Technology
  • Korean National Police Agency ((PA‐H000001))
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
skin-on-a-chip, in vitro skin model, microfluidic co-culture, skin inflammation, edema, TNF-α, inflammatory cytokines, skin barrier function, tight junctions, endothelial permeability, drug toxicity testing
MeSH terms
Dexamethasone, Edema, Humans, Immunohistochemistry, Inflammation, Models, Biological, Skin, Tumor Necrosis Factor-alpha, Tight Junctions, Protective Agents, Lab-On-A-Chip Devices, Human Umbilical Vein Endothelial Cells, Optical Imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.